Navigation Links
UCB, Inc. and Arthritis Foundation Partner to Celebrate the "Everyday Victories" of the Rheumatoid Arthritis Community
Date:12/11/2012

ATLANTA, Dec. 11, 2012 /PRNewswire/ -- UCB, Inc. and the Arthritis Foundation are proud to announce the launch of "Everyday Victories," a program designed to celebrate the individual accomplishments of people succeeding with rheumatoid arthritis (RA).  The program provides a platform for the 1.5 million Americans impacted by RA to share stories of their personal "everyday victories" over the condition.1  For each victory submitted by a person living with RA, UCB will provide $1 to the Arthritis Foundation up to $30,000. 

RA is a chronic condition that causes painful swelling and fatigue that can disrupt daily life.2  Due to the nature of the disease, seemingly simple achievements like buttoning a shirt, mowing the lawn or folding laundry can feel like a victory for people living with RA. 

"For many people who battle RA, accomplishing everyday tasks can be a cause for celebration.  That's why we've partnered with the Arthritis Foundation to shine a spotlight on these daily triumphs," said Carol Satler, MD, PhD, Vice President, U.S. Medical Affairs, UCB, Inc.  "As a patient-centric company committed to developing medications for immunologic diseases like RA, we at UCB are propelled forward by the strength that these exceptional people show in spite of the challenges that RA poses.  'Everyday Victories' is our way of honoring those individuals while helping them to draw inspiration from one another."

Those interested in participating can visit www.EverydayRAVictories.com to enter a victory, view select submissions or the amount of funds raised.  They can also share information about the program with their followers on Facebook, Google+ and Twitter.  Photo contributions to accompany victory submissions are welcome and encouraged.  Entries will be accepted beginning December 2012.

"My everyday victory is spending quality time with my children after school," said Lana B., a woman with RA and a blogger for Living Life as I See Fit.  "I've been handed my fair share of challenges thanks to RA, but my victory represents the mindset that while my condition may affect how I feel physically, it cannot control who I am – a mother, a legal professional, a blogger and an advocate for myself and others living with the condition.  Life with RA isn't always easy, but the inspiring stories shared through 'Everyday Victories' show us we can persevere."

The money raised will be used to help support the mission of the Arthritis Foundation, the largest national nonprofit organization dedicated to the prevention, control and cure of arthritis. 

"We welcome the opportunity to amplify the collective voices of the RA community, and thank UCB for their partnership and generosity in helping us advance our mission of improving the lives of those with arthritis," said Rick Bell, managing director of cause development for the Arthritis Foundation.  "This program supports patients in their quest to live a full life, despite the daily challenges wrought by a debilitating disease.  We call on the RA community to contribute their victories – not only for inspiration, but for the insight they will give us into the lives of the patients we serve."

To learn more about "Everyday Victories" or to submit a story detailing your own personal victory or that of a loved one, please visit www.EverydayRAVictories.com.  

For further Information:
Andrea Levin, Associate Director, U.S. Communications and Public Relations
770.970.8352, Andrea.Levin@ucb.com

Dena Koklanaris, Cooney/Waters Group
212.886.2228, DKoklanaris@cooneywaters.com

About Rheumatoid Arthritis
Rheumatoid Arthritis (RA) is a chronic autoimmune disease that mainly involves inflammation of the joints, including small joints in the hands and feet.2 RA can cause painful swelling that can interrupt daily activities and may eventually result in bone erosion and joint deformity if not adequately treated.2,3 RA affects more than 1.5 million Americans,1 and it is estimated that 5 million people suffer from RA globally.4  Prevalence is not split evenly between genders, since women are nearly three times more likely to be affected than men.5 Although RA can affect people of all ages, the onset of the disease usually occurs between 40-60 years of age.2

About the Arthritis Foundation
Striking one in every five adults and 300,000 children, arthritis is the nation's leading cause of disability. The Arthritis Foundation (www.arthritis.org) is committed to raising awareness and reducing the unacceptable impact of this serious and painful disease, which can severely damage joints and rob people of living life to its fullest. The Foundation funds life‐changing research that has restored mobility in patients for more than six decades; fights for health care policies that improve the lives of the millions who live with arthritis; and partners with families to provide empowering programs and information.

About UCB
UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 8,500 people in about 40 countries, the company generated revenue of EUR 3.2 billion in 2011. UCB is listed on Euronext Brussels (symbol: UCB).

References
1. Rheumatoid Arthritis, Centers for Disease Control and Prevention. Accessed November 5, 2012 from http://www.cdc.gov/arthritis/basics/rheumatoid.htm.
2. Rheumatoid Arthritis, Mayo Clinic. Accessed September 25, 2012 from http://www.mayoclinic.com/health/rheumatoid-arthritis/DS00020.
3. Rheumatoid arthritis pain: Tips for protecting your joints, Mayo Clinic. Accessed October 24, 2012 from http://www.mayoclinic.com/health/arthritis/AR00015/METHOD=print.
4. Rheumatoid Arthritis, UCB. Accessed September 25, 2012 from http://www.ucb.com/patients/conditions/immunology-inflammation/ra.
5. Rheumatoid Arthritis, National Institute of Arthritis and Musculoskeletal and Skin Diseases. Accessed October 24, 2012 from http://www.niams.nih.gov/Health_Info/Rheumatic_Disease/default.asp.

 


'/>"/>
SOURCE UCB
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Flexions Lead Osteoarthritis Drug Candidate Demonstrates Significant, Prolonged Improvement in Pain and Function in Phase 2 Trial
2. Lilly and Incytes Oral JAK1 and JAK2 Inhibitor, Baricitinib, Showed Positive Results in Phase IIb Study in Patients with Active Rheumatoid Arthritis
3. Innovations for Osteoarthritis, Sports Injuries and Orthopedic Practices
4. Arthritis Associates of South Florida Acquires Access to Patient Health History Faster with Digital Pen Technology from Anoto and NextGen Healthcare
5. United States Market for Psoriatic Arthritis Pharmacotherapy
6. TSI Healthcare adds Arthritis and Rheumatology Associates of Palm Beach to growing list of Rheumatology Clients
7. Rheumatoid Arthritis New Major Clinical Target After Mesoblast Obtains Positive Results in Inflammatory Arthritis
8. Janssen Announces Initiation Of Phase 3 Development Program For Sirukumab In Rheumatoid Arthritis
9. Protalex, Inc. Announces Screening Of First Patients In U.S. For New Trial Of PRTX-100 In Patients With Active Rheumatoid Arthritis
10. Phase 3 Data Show Intravenous Golimumab Inhibited Radiographic Progression in Patients with Active Rheumatoid Arthritis
11. Epidemiology: Rheumatoid Arthritis in China - Rapid urbanization presents favorable market potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , Feb. 4, 2016 Worldwide ... achieve significant growth as next generation systems provide ... use radiology for cancer surgery. New systems pinpoint ... overdosing that has been such a problem previously, ... delivered. Radiosurgery robots take cancer surgery far beyond ...
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... LONDON , Feb. 4, 2016 ... and competitive market to drive long-term market growth ... very common set of chronic disorders that affect ... disparate in terms of their symptoms and key ... by dysregulation of immune pathways and an inappropriate ...
Breaking Medicine Technology:
(Date:2/5/2016)... New York (PRWEB) , ... February 05, 2016 , ... ... use and find themselves having to wait longer to access the treadmills. It’s a ... New Year’s resolutions to lose weight and get in shape by joining gyms, starting ...
(Date:2/5/2016)... ... , ... At its annual meeting held last week, the American Parkinson Disease ... of Directors. Mr. McDermott succeeds former APDA Chairman, Fred Greene. , "We are pleased ... APDA President and CEO. “Pat has tirelessly served APDA since 2001 when he was ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Colorize ... on one drop zone to the next using Colorize's dynamic moving camera. Colorize is ... This package includes a 3D slideshow environment with 1 to 5 focus points per ...
(Date:2/5/2016)... ... 05, 2016 , ... On June 9-10, Las Vegas will ... education (CME) event presented by the Association for Comprehensive Care in Rare Diseases ... whose mission is to provide education, tools, and resources to primary care clinicians ...
(Date:2/5/2016)... Luis Obispo, CA (PRWEB) , ... February 05, 2016 , ... ... new changes that Medicare San Luis Obispo users can expect to see in 2016. ... , The two most significant changes will directly impact many San Luis Obispo seniors ...
Breaking Medicine News(10 mins):